For anyone wanting to know more about Bec's whacky world of TME, then boil the kettle and get ya Tim Tams out...and be prepared to consume your Sunday getting lost in of Tregs, Bregs, TAMs, TANs, MDSCs adn tDCs
I think i will leave it to the experts to tell us next week! But the following pretty much explains tumor immune suppression:-
The takeaway, for me, from this discussion prompted by @hottod, is that our CellPryme platform appears capable of attacking cancer cells from within and not just at the surface. And, that is why immunotherapy thus far has been inadequate in fighting solid tumors. But what now perplexes me (which should actually delight) is how the heck can such issues be addressed by technology at the cell manufacturing stage? TBH, that concept is mind-boggling! It almost equates to being a targeted therapy!? If this is what CellPryme has the potential to do, then make room for my full SPP allocation, please.
